SRRANASDAQHealthcare · Biotechnology

Sierra Oncology, Inc.

$54.99+0.00%(+$0.00)

TickerSpark Score

69/100

Solid

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRRA research report →

52-Week Range100% of range

Low $14.91

Current $54.99

High $55.19

Companywww.sierraoncology.com

Sierra Oncology, Inc. , a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally bioavailable Janus kinase 1 (JAK 1), JAK2, and Activin A receptor type 1 (ACVR1) inhibitor.

CEO: Nicholas Glover
IPO: 2015
Employees: 109
HQ: Vancouver, BC, CA

Price Chart

+178.71% · this period

Valuation

Market Cap: $0
P/E: -7.70
P/S: 0.00
P/B: 7.59
EV/EBITDA: 1.10
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -97.61%
ROIC: -97.74%

Growth & Income

Revenue: $0 · -100.00%
Net Income: $-94,659,000 · -17.00%
EPS: $-7.14 · 7.27%
Op Income: $-94,662,000
FCF YoY: -50.89%

Performance & Tape

52W High: $55.19
52W Low: $14.91
50D MA: $54.73
200D MA: $33.69
Beta: 0.02
Avg Volume: 651.46K

Get TickerSpark's AI analysis on SRRA

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Jul 1, 22	Vivo Opportunity, LLC	director, 10 percent owner:	sell	75,749	$999.89K
Jul 1, 22	Vivo Opportunity, LLC	director, 10 percent owner:	sell	431,947	$23.76M
Jul 1, 22	ORBIMED ADVISORS LLC	director, 10 percent owner:	sell	170,437	$2.25M
Jul 1, 22	ORBIMED ADVISORS LLC	director, 10 percent owner:	sell	226,704	$12.47M
Jul 1, 22	Ashiya Mona	director, 10 percent owner:	sell	170,437	$2.25M
Jul 1, 22	Ashiya Mona	director, 10 percent owner:	sell	1,500	$20.80K
Jul 1, 22	Ashiya Mona	director, 10 percent owner:	sell	6,000	$108.66K
Jul 1, 22	Ashiya Mona	director, 10 percent owner:	sell	6,874	$96.10K
Jul 1, 22	Ashiya Mona	director, 10 percent owner:	sell	226,704	$12.47M
Jul 1, 22	Sinclair Andrew	director	sell	6,000	$108.66K